Skip to Main Content

Paper Details

Targeting the IRAK1-S100A9 Axis Overcomes Resistance to Paclitaxel in Nasopharyngeal Carcinoma.
Cancer Res
16
2021
IRAK1, Nasopharyngeal Carcinoma, Paclitaxel, S100A9, candidate gene, late, nasopharyngeal, nasopharyngeal carcinoma, paclitaxel, paclitaxel-resistant nasopharyngeal carcinoma cells, paclitaxel-sensitive and -resistant cell lines, pacritinib
Author NameAffiliation
Rong XiaoState Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center
Qiang YuDuke-NUS Medical School
Qiang YuGenome Institute of Singapore
Qiang YuYong Loo Lin School of Medicine, National University of Singapore
  • 1 - 4

Datasets

Release 1.2